company background image
BXN

Bioxyne ASX:BXN Stock Report

Last Price

AU$0.023

Market Cap

AU$15.3m

7D

-4.2%

1Y

-17.9%

Updated

07 Dec, 2022

Data

Company Financials
BXN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BXN Stock Overview

Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products.

Bioxyne Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bioxyne
Historical stock prices
Current Share PriceAU$0.023
52 Week HighAU$0.029
52 Week LowAU$0.011
Beta0.54
1 Month Change-8.00%
3 Month Change43.75%
1 Year Change-17.86%
3 Year Change64.29%
5 Year Change-74.44%
Change since IPO-87.90%

Recent News & Updates

Recent updates

Shareholder Returns

BXNAU Personal ProductsAU Market
7D-4.2%-0.4%-0.03%
1Y-17.9%-41.9%-4.1%

Return vs Industry: BXN exceeded the Australian Personal Products industry which returned -41.9% over the past year.

Return vs Market: BXN underperformed the Australian Market which returned -4.1% over the past year.

Price Volatility

Is BXN's price volatile compared to industry and market?
BXN volatility
BXN Average Weekly Movement21.6%
Personal Products Industry Average Movement8.6%
Market Average Movement8.9%
10% most volatile stocks in AU Market15.9%
10% least volatile stocks in AU Market4.1%

Stable Share Price: BXN is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 22% a week.

Volatility Over Time: BXN's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1998n/aNam Chuahttps://www.bioxyne.com

Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products. It perates in two segments, Wholesale Sales and Direct Sales. The company engages in developing various functional foods and beauty products.

Bioxyne Limited Fundamentals Summary

How do Bioxyne's earnings and revenue compare to its market cap?
BXN fundamental statistics
Market CapAU$15.31m
Earnings (TTM)-AU$236.51k
Revenue (TTM)AU$2.48m

6.2x

P/S Ratio

-65.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BXN income statement (TTM)
RevenueAU$2.48m
Cost of RevenueAU$1.26m
Gross ProfitAU$1.22m
Other ExpensesAU$1.46m
Earnings-AU$236.51k

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.00035
Gross Margin49.28%
Net Profit Margin-9.52%
Debt/Equity Ratio0.0%

How did BXN perform over the long term?

See historical performance and comparison